Malaria treatment safety in early pregnancy
Treatments studied
Part of Infections clinical trials.
This trial tests how safe antimalarial drugs are during the first few months of pregnancy. It aims to find treatments that protect both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 weeks and 14 weeks pregnant (as confirmed by ultrasound).
- You have a malaria infection with the P. falciparum parasite, with or without symptoms.
- You are at least 16 years old or an emancipated minor.
- You live near a participating health center and plan to deliver there.
- You agree to follow the study schedule and deliver at the local facility.
- You have not taken certain antimalarial medicines in the last 2 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a malaria prevention drug (DHA-PQP) to pregnant women in Kasese District can reduce malaria in pregnancy. Pregnant women at Bugoye Health Center who are less than 22 weeks along may join.
This study follows people who were pregnant while receiving IV artesunate to better understand the treatment’s safety for both the mother and the baby. It does not test a new treatment—it collects safety information from real-world care.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
This study tests how well malaria treatments work in Ethiopia. It aims to find the best medicines for uncomplicated malaria caused by certain parasites, helping patients recover fully and preventing future drug resistance.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This study tests a medicine given to mothers after childbirth to see how it passes into breast milk and if it is safe for babies. It may help prevent malaria relapse in mothers who have had vivax malaria.
Hear when a new Malaria, Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.